Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.71 - $2.43 $43,381 - $148,473
-61,100 Reduced 98.7%
803 $1,000
Q1 2022

May 05, 2022

BUY
$2.31 - $5.13 $154 - $343
67 Added 0.11%
61,903 $147,000
Q4 2021

Feb 02, 2022

SELL
$4.45 - $8.09 $912 - $1,658
-205 Reduced 0.33%
61,836 $294,000
Q3 2021

Nov 02, 2021

SELL
$6.94 - $8.85 $84,383 - $107,607
-12,159 Reduced 16.39%
62,041 $486,000
Q2 2021

Aug 02, 2021

BUY
$7.45 - $16.27 $552,790 - $1.21 Million
74,200 New
74,200 $599,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.